Correction of tear trough deformity with novel porcine collagen dermal filler (Dermicol-P35).
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19577181.
- Also identified by DOI 10.1016/j.asj.2009.02.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Deformity of the tear trough region, which can occur during the aging process, can result in dark shadows under the eyes and a fatigued appearance. Augmentation of the tear trough is challenging because of the thin skin and lack of fat in the region. Adding volume to the tear trough region with a dermal filler is a nonsurgical procedure with minimal discomfort to the patient. Dermicol-P35 (Evolence; Ortho Dermatologics, Skillman, NJ) is a new, ribose crosslinked, highly purified, porcine-based collagen filler that does not require prior skin testing and has shown improved persistence compared with bovine collagen-based dermal fillers. In this article, we present the clinical outcomes of patients who have received treatment with a novel ribose crosslinked porcine collagen dermal filler for the correction of tear trough deformity.
Medical subject headings
- Biocompatible Materials
- Collagen
- Cosmetic Techniques
- Dermatologic Agents
- Eyelids
- Rejuvenation
- Skin Aging